Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
336.8 USD | -3.44% | -6.58% | +2.30% |
May. 22 | Deutsche Bank Adjusts Waters Price Target to $330 From $304 | MT |
May. 16 | Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With an expected P/E ratio at 32.29 and 28.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.30% | 20.69B | A- | ||
+10.22% | 226B | B | ||
+12.99% | 198B | B- | ||
+18.09% | 142B | B- | ||
+28.66% | 111B | A- | ||
+2.09% | 65.26B | A- | ||
+14.70% | 54.36B | B+ | ||
+6.68% | 50.94B | B+ | ||
+8.29% | 44.8B | A | ||
+2.60% | 36.8B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- WAT Stock
- Ratings Waters Corporation